Genetically Modified Microorganisms: Risks and Regulatory Considerations for Human and Environmental Health
Microorganisms · 14.02.2026 · 14 (2) · 467
DOI: 10.3390/microorganisms14020467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 14.02.2026. Verfasst von Aaron Lerner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chaim Sheba Medical Center, The Zabludowicz Center for Autoimmune Diseases, Ahazmaout St. No. 8, Petach Tikva 4937908, Israel. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in affordable genetic engineering have accelerated the creation and large-scale environmental release of genetically modified microorganisms (GMMs). While beneficial applications exist, GMMs may present unique, long-term risks to human and environmental health. Unlike static chemicals, GMMs are biologically active, self-replicating entities capable of rapid mutation and global dispersal. Current regulatory frameworks place responsibility on each country to regulate GMMs, without a clear, coordinated international policy. This review details critical risk scenarios, including horizontal gene transfer to native species and the possible disruption of vital human microbiomes (gut, oral, and infant), which could increase resistance to degradation, promote traits that expand a microbe’s range of hosts or ecological niches, and enhance the production of novel metabolites with unexpected biological activity. In soil, GMMs may support the emergence of “super bugs” or destabilize carbon sequestration cycles, potentially impacting climate resilience. Engineered microbial enzymes in the food supply may also act as environmental drivers of autoimmunity. Given the limited understanding of microbial ecology, we propose a decision-based biosafety workflow emphasizing pre-release risk assessment and continuous post-release monitoring. We urge national and international regulators to adopt the precautionary principle to better protect human health and the environment from the potential negative outcomes of GMMs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chaim Sheba Medical Center, The Zabludowicz Center for Autoimmune Diseases, Ahazmaout St. No. 8, Petach Tikva 4937908, Israel.
- Independent Researcher, 47 Maale Uria St., Kfar Uria 9973500, Israel.
- Health First Consulting, LLC, 1600 Indian Brook Way, Norcross, GA 30093, USA.
- Regeneration International, 2543 Mossman Daintree Road, Lower Daintree, QLD 4873, Australia.
- GMOScience, 769 Center Blvd., Suite 101, Fairfax, CA 94930, USA.
- Petrichor Consulting Group LLC, Chico, CA 95965, USA.
ORCID-Profile: Aaron Lerner, Andre Leu, Carina Benzvi
Zitieren
APA
Lerner, A., Lieber, A. D., Nelson-Dooley, C., Leu, A., Perro, M., Koch, G., Benzvi, C., & Smith, J. (2026). Genetically Modified Microorganisms: Risks and Regulatory Considerations for Human and Environmental Health. Microorganisms, 14(2), 467. https://doi.org/10.3390/microorganisms14020467
Vancouver
Lerner A, Lieber AD, Nelson-Dooley C, Leu A, Perro M, Koch G, et al. Genetically Modified Microorganisms: Risks and Regulatory Considerations for Human and Environmental Health. Microorganisms. 2026;14(2):467. doi:10.3390/microorganisms14020467
BibTeX
@article{Lerner2026,
author = {Lerner, Aaron and Lieber, Arnon D and Nelson-Dooley, Cass and Leu, Andre and Perro, Michelle and Koch, Geoffrey and Benzvi, Carina and Smith, Jeffrey},
title = {Genetically Modified Microorganisms: Risks and Regulatory Considerations for Human and Environmental Health},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {2},
pages = {467},
doi = {10.3390/microorganisms14020467}
}
EUVIMED